Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Keloid Scar”

8 trials

Showing 8 of 8 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06965088
What this trial is testing

Comparison of Recurrence Rate of Keloid After Excision Between Intra-operative Steroid Injection and Steroid With Platelet-rich Plasma Injection Combination Therapy

Who this might be right for
Patients With Keloid Scar
Ramathibodi Hospital 212
Not applicableStudy completedNCT07420166
What this trial is testing

Comparison of Intralesional Triamcinolone Acetonide Treatment With Intralesional Verapamil Hydrochloride in Keloids

Who this might be right for
Keloid
Muhammad Aamir Latif 60
Not applicableUnknownNCT01627769
What this trial is testing

Evaluation and Comparison of Keloids and Second Degree Burns Blisters Fluid

Who this might be right for
BlistersSecond Degree BurnsWounds
Carmel Medical Center 20
Not applicableStudy completedNCT01125137
What this trial is testing

Case-control Study on Matrix Metalloproteinase Levels in Tissue in Patients With Keloid Scar

Who this might be right for
Keloid
Henry Ford Health System 20
Testing effectiveness (Phase 2)WithdrawnNCT02546076
What this trial is testing

Comparison of Dual-mode ER:YAG Laser in Patients With Long Keloid/Hypertrophic Scars

Who this might be right for
KeloidHypertrophic Scars
Insel Gruppe AG, University Hospital Bern
Testing effectiveness (Phase 2)Looking for participantsNCT06373458
What this trial is testing

Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy

Who this might be right for
Keloid
Icahn School of Medicine at Mount Sinai 30
Testing effectiveness (Phase 2)Ended earlyNCT01425216
What this trial is testing

Sorafenib for Patients With Extensive Keloids

Who this might be right for
Keloids
Tirgan, Michael H., M.D. 60
Testing effectiveness (Phase 2)Ended earlyNCT01408953
What this trial is testing

Therapeutic Study of Bevacizumab Injection Directly Inside the Keloid Tissue

Who this might be right for
Keloid
Tirgan, Michael H., M.D. 2

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation